Financial Statements · Financial Reporting
osaühing TBD Pharmatech
Official identifier 11204964Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 29 Jun 2026
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 11,379,553 |
| Balance sheet | Cash and cash equivalents | 1,322,974 |
| Balance sheet | Current assets | 2,934,029 |
| Balance sheet | Current liabilities | 771,923 |
| Balance sheet | Equity | 6,829,858 |
| Balance sheet | Share capital at nominal value | 7,136 |
| Balance sheet | Non-current assets | 8,445,524 |
| Balance sheet | Non-current liabilities | 3,777,772 |
| Balance sheet | Retained earnings (loss) from previous periods | 5,784,510 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -186,965 |
| Income statement scheme 1 | Labour costs | -2,699,686 |
| Income statement scheme 1 | Revenue | 5,116,467 |
| Income statement scheme 1 | Annual period profit / loss | 499,563 |
| Income statement scheme 1 | Operating profit (loss) | 612,846 |
| Income statement scheme 1 | Profit (loss) before income tax | 499,563 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 5,784,510 |
| Note: Labour costs | Employees | 62 |
| Note: Labour costs | Labour costs | -2,699,686 |
| Rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 186,965 |
| Rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 612,846 |
Linked company
Company: osaühing TBD Pharmatech